Latest filing published 02 Jan 2020 for Ernexa Therapeutics Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -54.4%Entry US$65,850.00 · Close at T+365 US$30,000.00
- -44.7%Entry US$59,100.00 · Close at T+365 US$32,700.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Richard Isaac Simtob: trading record in brief
Richard Isaac Simtob appears in our data through filings on Ernexa Therapeutics Inc. shares, published by SEC (Form 4). In total, 7 filings cover trades dated from 29 September 2017 to 31 December 2019.
Every open-market trade on record is a purchase: 5 purchases worth €36k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants.
The median purchase comes to €2,711. None of the 5 purchases we analysed coincided with buying by another insider of the same company within 30 days. After 5 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +30.5%. This is a record of the past, not a forecast.
Most recently, on 2 January 2020, the filings show a share grant in Ernexa Therapeutics Inc. The last insider purchase was made public on 18 December 2017, 3,248 days ago. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Richard Isaac Simtob
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,851 shares0Common StockSEC:0001493152-20-000071:0
- 100 shares@ US$3.900.9% of flowCommon StockSEC:0001493152-17-014733:0Canonical exit: 15 Mar 2018 (T+90)
- 5,552 shares@ US$4.0052.5% of flowCommon StockSEC:0001493152-17-014733:1Canonical exit: 18 Mar 2018 (T+90)
- 4,100 shares@ US$3.9538.1% of flowCommon StockSEC:0001493152-17-014321:0Canonical exit: 7 Mar 2018 (T+90)
- 100 shares@ US$3.970.9% of flowCommon StockSEC:0001493152-17-014321:1Canonical exit: 7 Mar 2018 (T+90)
- 800 shares@ US$4.007.5% of flowCommon StockSEC:0001493152-17-014321:2Canonical exit: 7 Mar 2018 (T+90)
- 1,337 shares0Common StockSEC:0001493152-17-011197:0
7 of 7 declarations
